Lexotan 3 mg tabletter 덴마크 - 덴마크어 - Lægemiddelstyrelsen (Danish Medicines Agency)

lexotan 3 mg tabletter

2care4 aps - bromazepam - tabletter - 3 mg

Stesolid 5 mg/dosis rektalvæske, opløsning, enkeltdosisbeholder 덴마크 - 덴마크어 - Lægemiddelstyrelsen (Danish Medicines Agency)

stesolid 5 mg/dosis rektalvæske, opløsning, enkeltdosisbeholder

orifarm a/s - diazepam - rektalvæske, opløsning, enkeltdosisbeholder - 5 mg/dosis

Maviret 유럽 연합 - 덴마크어 - EMA (European Medicines Agency)

maviret

abbvie deutschland gmbh co. kg - glecaprevir, pibrentasvir - hepatitis c kronisk - antivirale midler til systemisk anvendelse - maviret is indicated for the treatment of chronic hepatitis c virus (hcv) infection in adults and children aged 3 years and older. maviret coated granules is indicated for the treatment of chronic hepatitis c virus (hcv) infection in children 3 years and older.

Engerix-B 10 mikrogram/0,5 ml 20 mikrogram/ml injektionsvæske, suspension 덴마크 - 덴마크어 - Lægemiddelstyrelsen (Danish Medicines Agency)

engerix-b 10 mikrogram/0,5 ml 20 mikrogram/ml injektionsvæske, suspension

glaxosmithkline pharma a/s - hepatitis b virus overfladeantigen (rdna) - injektionsvæske, suspension - 20 mikrogram/ml

Glepark 0,088 mg tabletter 덴마크 - 덴마크어 - Lægemiddelstyrelsen (Danish Medicines Agency)

glepark 0,088 mg tabletter

glenmark arzneimittel gmbh - pramipexoldihydrochloridmonohydrat - tabletter - 0,088 mg

Sepan 25 mg tabletter 덴마크 - 덴마크어 - Lægemiddelstyrelsen (Danish Medicines Agency)

sepan 25 mg tabletter

paranova danmark a/s - cinnarizin - tabletter - 25 mg

Pegasys 유럽 연합 - 덴마크어 - EMA (European Medicines Agency)

pegasys

pharmaand gmbh - peginterferon alfa-2a - hepatitis c, chronic; hepatitis b, chronic - immunostimulants, - chronic hepatitis b adult patients pegasys is indicated for the treatment of hepatitis b envelope antigen (hbeag)-positive or hbeag-negative chronic hepatitis b (chb) in adult patients with compensated liver disease and evidence of viral replication, increased alanine aminotransferase (alt) and histologically verified liver inflammation and/or fibrosis (see sections 4. 4 og 5. paediatric patients 3 years of age and older pegasys is indicated for the treatment of hbeag-positive chb in non-cirrhotic children and adolescents 3 years of age and older with evidence of viral replication and persistently elevated serum alt levels. med hensyn til beslutningen om at indlede behandling hos pædiatriske patienter, se afsnit 4. 2, 4. 4 og 5. chronic hepatitis c adult patients pegasys is indicated in combination with other medicinal products, for the treatment of chronic hepatitis c (chc) in patients with compensated liver disease (see sections 4. 2, 4. 4 og 5. for at hepatitis c virus (hcv) genotype specifik aktivitet, se afsnit 4. 2 og 5. paediatric patients 5 years of age and older pegasys in combination with ribavirin is indicated for the treatment of chc in treatment-naïve children and adolescents 5 years of age and older who are positive for serum hcv-rna. når det besluttes at indlede behandling i barndommen, er det vigtigt at overveje, væksthæmning, der er fremkaldt af en kombination terapi. reversibilitet af væksthæmning er usikker. beslutningen om at behandling skal ske på grundlag af en individuel vurdering (se afsnit 4.

Hexalid 2 mg tabletter 덴마크 - 덴마크어 - Lægemiddelstyrelsen (Danish Medicines Agency)

hexalid 2 mg tabletter

sandoz a/s - diazepam - tabletter - 2 mg

Hexalid 5 mg tabletter 덴마크 - 덴마크어 - Lægemiddelstyrelsen (Danish Medicines Agency)

hexalid 5 mg tabletter

sandoz a/s - diazepam - tabletter - 5 mg

Uman Big 180 IE/ml injektionsvæske, opløsning 덴마크 - 덴마크어 - Lægemiddelstyrelsen (Danish Medicines Agency)

uman big 180 ie/ml injektionsvæske, opløsning

kedrion s.p.a. - hepatitis b immunglobulin, humant - injektionsvæske, opløsning - 180 ie/ml